Expect another 8 percent in after hours. It's a record quarter and growing on all cylinders. BUY AS MUCH AS YOU CAN,!
According to trade alert, based on an options strategy called a straddle, shares should move about 8.3
percentage up or down.Its actually smaller than the average 10.3% move over its last eight earning reports.
700 of course that's why I invested all my money and will keep it and sell a week later because it will go up
some more after a week.
What do you think happened?
Whats wrong with this stock when competitor is out of the race? Why is it falling so much?
BioMarin Pharmaceutical (NASDAQ:BMRN) receives a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking clearance of Kyndrisa (drisapersen) for the treatment of Duchenne muscular dystrophy amenable to exon 51 skipping. A CRL means that the company's NDA is not approvable in its present form.